The effect of carbon tetrachloride (CC1 4 ) on aflatoxin B 1 (AFB 1 )-induced enzyme altered hepatic foci has been examined in young male Fischer rats given AIN-76A diet. A single i.p. dose of AFB 1 (0.2 mg/kg body wt) was given to rats 24 h after partial hepatectomy. Two weeks later, CCl 4 (0.8 ml/kg body wt) was injected i.p. once a week for 9 weeks. Animals were sacrificed 24 h after the last dose of CC1 4 and glutathione S-transferase placental form (GST-P) and -glutamyl transpeptidase (GGT) positive hepatic foci were analyzed by immunohistochemical and histochemical methods, respectively. Ten weeks after A F B 1 dosing, treatment with CCl 4 increased the number of AFB 1 -induced enzyme altered foci several fold and produced a ten to twenty-fold increase in area and volume. GST-P was more sensitive than GGT in detecting AFB 1 -i n d u c e d enzyme altered foci. Treatment with AFB 1 or CCl 4 produced mild hepatic fibrosis in zones 1 and 3 r e s p e c t i v e l y, whereas both treatments produced severe fibrosis in zones 1 to 3 areas. Tr e a t -ment with CCl 4 after AFB 1 dosing lowered hepatic GSH levels by 20% and increased lipid peroxidation by 40%. It appears that CCl 4 , by being an effective enhancer of AFB 1 -induced enzyme altered hepatic foci in the rat, may mimic cirrhosis observed in human hepatocellular carcinoma.
Introduction
On the basis of epidemiological data, it has been established that one of the factors responsible for human liver cancer is aflatoxin B 1 ( A F B 1 ), a mycotoxin produced by Aspergillus flavus (IARC Monographs, 1993) . Development of human hepatocellular carcinoma is closely associated with liver cirrhosis produced by hepatitis virus infection and heavy consumption of alcohol (Doll and Peto, 1981; Tribelli et al., 1989) . Even though a rat is the most susceptible laboratory animal species to AFB 1 hepatocarcinogenesis (Newberne and Butler, 1969 ; Eaton and G a l l a g h e r, 1994), cirrhosis is not observed in this species even in the presence of various promoters including phenobarbital (Newberne and Butler, 1969; KrauppGrasl et al., 1990; Hiruma et al., 1997) .
Compensatory cell proliferation induced by either partial hepatectomy (PH) or carbon tetrachloride (CCl 4 ) plays an important role in the initiation of rat liver carcinogenesis by various chemicals including AFB 1 as examined by enzyme altered foci (Warwick, 1971; Cayama et al., 1978; Pitot et al., 1978; Columbano et al., 1987; Hiruma et al., 1996) . Previous studies with diethylnitrosamine and A F B 1 have indicated that early glutathione Stransferase placental form (GST-P) positive hepatocytes induced by these carcinogens are the precursors for preneoplastic foci and nodules (Moore et al., 1987; Satoh et al., 1989; Tsuji et al., 1992; Dragan et al., 1994; Hiruma et al., 1996 Hiruma et al., , 1997 . Repeated administration of C C l 4 to rats, has enhanced nitrosamine-induced formation of enzyme altered hepatic foci and nodules (Columbano et al. , 1990; Zalatnai et al., 1991; Cho and Jang, 1993) . It is also known that repeated administration of CCl 4 to rats results in cirrhosis of the liver (PerezTamayo, 1983; Gasso et al., 1996) .
In the present study, we have evaluated the effect of CCl 4 on AFB 1 -induced enzyme altered hepatic foci. The results of this study indicate that CCl 4 is an eff e c t i v e enhancer of AFB 1 -induced enzyme altered hepatic foci in the rat. In addition, CCl 4 treatment enhances hepatic fibrosis and lipid peroxidation.
Glycylglycine, diaminobenzidine, AFB 1 , dimethylsulfoxide (DMSO), HPLC grade CCl 4 , bromodeoxyuridine (BrdU), mouse anti-BrdU antibody, glutathione (GSH) and 5,5'-dithiobis-(2-nitrobenzoic acid) were purchased from Sigma Chemical Co., St. Louis, MO. γ-G l u t a m y l -4 -m e t h o x y -2 -naphthylamide was bought from United States Biochemical Corporation, Cleveland, OH. Inhalation anesthetic, methoxyflurane (2,2-dichloro-1-1-difluoroethyl methyl ether) was obtained from Pittman Moore Inc., Wa s h i n g t o n Crossing, NJ. Vectastain ABC kit for immunohistochemical staining was purchased from Vector Laboratories Inc., Burlingame, CA. AIN-76A diet (Second Report, 1980) was bought from Dyets Inc., Bethlehem, PA. All other chemicals were of reagent grade.
Animals and treatment
Thirty four male Fischer rats, 6-7 weeks old (90-100 g body wt) purchased from Charles River Breeding Laboratories, Wilmington, MA, were housed in plastic cages with hard wood chips for bedding in an airconditioned room at 23 ± 2°C with a 12 h light/dark cycle. They were maintained on AIN-76A diet and given tap water for 10 days before use.
A two-thirds partial hepatectomy (PH) was performed on all animals under methoxyflurane anesthesia according to the published procedure (Higgins and Anderson, 1931) . Earlier studies indicated that the maximum initiation occurs when various carcinogens including AFB 1 are administered at the peak of DNA synthesis. In the rat liver, maximal DNA synthesis occurs 20-24 h after PH (Warwick, 1971; Scherer and Emmelot, 1976; Cayama et al., 1978; Pitot et al., 1978;  C o l u m b a n o et Hiruma et al., 1996; ) . In the present study therefore, sixteen animals were injected intraperitoneally (i.p.) with DMSO and the remaining 18 animals were injected i.p. with AFB 1 (0.2 mg/kg body wt) dissolved in DMSO 24 h after PH to induce maximum initiation of carcinogenesis. All animals were maintained on AIN-76A diet throughout the experimental period. Two weeks after either DMSO or A F B 1 dosing, sixteen animals were injected i.p. with corn oil and 18 animals were injected i.p. with CCl 4 (0.8 ml/kg body wt) dissolved in corn oil once a week for 9 weeks. Twenty four h after the last dose of either corn oil or CCl 4 treatment, all animals were sacrificed.
To examine liver cell proliferation, all animals were injected i.p. with BrdU (100 mg/kg body wt) dissolved in saline 1 h before sacrifice.
Histopathology
After the animals were sacrificed by exsanguination under C O 2 euthanasia, livers were excised and weighed. Some liver sections cut into 2-3 mm thick sections with a razor blade were fixed in 10% phosphate buff e r e d formalin for routine staining with hematoxylin and eosin (H&E) as well as for immunohistochemical detection of BrdU and GST-P, whereas other sections were fixed in ice-cold acetone for histochemical determination of γ-glutamyl-transpeptidase (GGT).
GST-P staining
The immunohistochemical demonstration of GST-P antibody binding was by the avidin-biotin peroxidase method of Hsu et al. (1981) . The sites of peroxidase binding were detected by the diaminobenzidine method (Graham and Karnofsky, 1966) .
GGT staining
The histochemical staining for GGT was performed according to the published method (Rutenberg et al., 1969 ) using γ-glutamyl-4-methoxy-2-naphthylamide as a substrate.
Quantitation of GST-P and GGT positive hepatic foci
By taking one section from each lobe, about 3-4 cm 2 of 187 CCl4 Potentiation of AFB1-Induced Foci Table 1 . Enhancement of AFB1-induced GST-P positive hepatic foci in rats by treatment with carbon tetrachloride a .
GST-P positive hepatic foci (>100 µm in diameter) liver from each animal was examined for GST-P and GGT. The enzyme altered hepatic foci were counted with the use of a light microscope. Diameters of these foci were determined with an eyepiece micrometer. Areas of these foci were calculated from diameters of these foci. The number of foci per cm 2 was converted to the number of foci per cm 3 , with the conditional stereologic estimater of Enzmann et al. (1987) as modified recently with the 'Spheres' software program developed by Bayer A.G. in Germany.
BrdU positive cells
BrdU positive cells were detected by an immunohistochemical staining method (Hsu et al., 1981) as described by Sugihara et al. (1986) . The sites of peroxidase binding were detected by the diaminobenzidine method (Graham and Karnofsky, 1966) . At least 1000 hepatocytes were counted for each section to determine BrdU positive cells.
Fibrosis
Fibrosis observed in H&E stained sections was graded as follows: Zone 1 represents a periportal area of the liver lobule only; zone 3 represents a pericentral area of the lobule only; zone 1 to zone 3 represents periportal to pericentral areas including zone 2 area.
Other assays
Hepatic GSH levels were assayed according to E l l m a n 's procedure (1959) in the presence of 1M HEPES buff e r, pH 8.3. Concentrations of malondialdehyde (MDA) in liver homogenates were estimated by using a thiobarbituric acid method (Buege and Aust, 1978) . The MDA concent-ration was determined using a molar extinction coefficient o f 156,000. Results are expressed as nmol of MDA formed per g liver tissue. The significance of the data was statistically evaluated using Student's t-test. Values of P < 0.05 were considered statistically significant.
Results
Ten weeks after AFB 1 dosing, appreciable numbers of G S T-P positive hepatic foci could be detected even though the area of these foci was small (Table 1 ). In the absence of AFB 1 dosing or multiple doses of weekly CCl 4 treatment alone did not yield any GST-P positive hepatic foci. However, weekly treatment of CCl 4 t o A F B 1 -treated rats produced a 2-3 fold higher number of G S T-P positive hepatic foci with a ten fold increase in area and volume compared to animals administered with AFB 1 only. Treatment with CCl 4 increased the number of AFB 1 -induced GGT positive hepatic foci several fold with a twenty fold increase in area and volume (Table 2) .
Data on the effects of CCl 4 treatment on hepatic fibrosis, cellular proliferation, GSH levels and lipid peroxidation are summarized in Table 3 . Dosing of AFB 1 alone produced hepatic fibrosis in the zone 1 area only, whereas CCl 4 treatment alone produced fibrosis in the zone 3 area only. Treatment of CCl 4 subsequent to AFB 1 dosing produced severe fibrosis (cirrhosis) in zones 1 to 3. Cellular proliferation as measured by BrdU incorporation was very low in DMSO or AFB 1 dosed animals. However, cellular proliferation was several fold higher in CCl 4 t r e a t e d animals injected with or without AFB 1 . Hepatic GSH levels were lowered by 20% in animals treated with C C 1 4 after either DMSO or AFB 1 dosing. Treatment with C C l 4 increased lipid peroxidation by 25% and 40% in control and AFB 1 injected animals, respectively.
Discussion
In the present study, a single i.p. dose of AFB 1 (0.2 mg/kg body wt) given to rats 24 h after PH without CC1 4 treatment did yield some enzyme altered hepatic foci when animals were sacrificed at 10 weeks after the carcinogen administration (Tables 1 and 2 ). However, weekly treatment of CCl 4 enhanced AFB 1 -induced enzyme altered foci several fold both in area and volume. The present results are thus in agreement with previous data of other investigators who demonstrated that repeated CCl 4 treatment of various rodent species including rats enhanced nitrosamine-initiated hepatocytes to form enzyme altered foci and nodules (Pound and McGuire, 1978; Dragani et al., 1986 ; Ta n a k a et Columbano et al., 1990; Zalatnai et al., 1991; Cho and Jang, 1993) . In earlier studies, GGT was widely used as an enzyme marker for detecting the production of enzyme altered foci in rodent hepatocarcinogenesis (Kalengayi et al., 1975 ; C a y a m a et Pitot et al., 1978; Columbano e t al., 1987) . In the present study, it is apparent that GST-P is more sensitive than GGT in detecting production of AFB 1 -induced and CCl 4 -enhanced enzyme altered foci. These results are in agreement with other data on enzyme altered foci obtained with nitrosamine hepatocarcinogenesis from several laboratories (Satoh et al., 1985; Xu et al., 1990; Ledda-Columbano et al., 1992) .
It has been shown that CCl 4 -induced compensatory cell proliferation and not mitogen-induced cell proliferation is responsible for enhancement of nitrosamine initiated hepatocarcinogenesis (Columbano et al., 1987; Ledda-C o l u m b a n o et al., 1992) . Our previous studies on cellular proliferation examined by BrdU incorporation in the rat indicated optimum hepatic proliferation at 24 h after a single i.p. dose of CCl 4 (0.4 ml/kg body wt) where about 30% of the cells were labeled (Hiruma et al., 1997) . In the present study h o w e v e r, cell proliferation examined in the whole liver 24 h after the last CCl 4 treatment was much lower than that observed in our previous study. There is no satisfactory explanation to account for this discrepancy.
Lowering of hepatic GSH levels and enhanced lipid peroxidation after repeated administration of CCl 4 to rats reported previously (Aguilar-Delfin et al., 1996; Corrales et al. , 1992; Gasso et al. , 1996) are in agreement with our present data. However, in the present study, lipid peroxidation was enhanced significantly in animals dosed with AFB 1 before CCl 4 treatment. It may be useful to employ hepatic lipid peroxidation as a biochemical marker during CCl 4 enhancement of AFB 1 -initiated hepatocarcinogenesis.
In experimental CCl 4 -induced cirrhosis in the rat, initial necrotic lesions are observed in the centrilobular zone 3 area where fibrosis also occurs (Perez-Tamayo, 1983) , whereas during AFB 1 h e p a t o t o x i c i t y, the carcinogen produces periportal zone 1 necrosis (Newberne and Butler, 1969; Moore et al., 1987) . Our present data on hepatic fibrosis with AFB 1 or CCl 4 alone occurring in zones 1 and 3 respectively are in agreement with data reported previously by other investigators (Newberne and Butler, 1969; Perez-Tamayo, 1969; Moore et al., 1987) . However, CCl 4 treatment subsequent to AFB 1 administration producing severe fibrosis from zones 1 to 3 in the present study suggests that CCl 4 in the rat may mimic cirrhosis observed in human hepatocellular carcinoma (Doll and Peto, 1981; Tribelli et al., 1989) .
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